Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1793 1
1958 1
1960 2
1961 2
1963 1
1965 7
1966 11
1967 2
1968 9
1969 10
1970 6
1971 10
1972 4
1973 7
1974 12
1975 8
1976 10
1977 11
1978 6
1979 5
1980 3
1983 1
1984 4
1985 11
1986 3
1987 4
1988 8
1989 8
1990 10
1991 12
1992 8
1993 8
1994 15
1995 15
1996 22
1997 13
1998 19
1999 13
2000 19
2001 16
2002 24
2003 21
2004 33
2005 34
2006 43
2007 58
2008 56
2009 75
2010 60
2011 74
2012 96
2013 107
2014 109
2015 141
2016 127
2017 157
2018 127
2019 167
2020 235
2021 298
2022 329
2023 279
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

2,707 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop.
Bilezikian JP, Khan AA, Silverberg SJ, Fuleihan GE, Marcocci C, Minisola S, Perrier N, Sitges-Serra A, Thakker RV, Guyatt G, Mannstadt M, Potts JT, Clarke BL, Brandi ML; International Workshop on Primary Hyperparathyroidism. Bilezikian JP, et al. Among authors: khan aa. J Bone Miner Res. 2022 Nov;37(11):2293-2314. doi: 10.1002/jbmr.4677. Epub 2022 Oct 17. J Bone Miner Res. 2022. PMID: 36245251 Free article. Review.
Therapeutic Antiaging Strategies.
Mishra SK, Balendra V, Esposto J, Obaid AA, Maccioni RB, Jha NK, Perry G, Moustafa M, Al-Shehri M, Singh MP, Khan AA, Vamanu E, Singh SK. Mishra SK, et al. Among authors: khan aa. Biomedicines. 2022 Oct 8;10(10):2515. doi: 10.3390/biomedicines10102515. Biomedicines. 2022. PMID: 36289777 Free PMC article. Review.
Management of Primary Hyperparathyroidism.
Bilezikian JP, Silverberg SJ, Bandeira F, Cetani F, Chandran M, Cusano NE, Ebeling PR, Formenti AM, Frost M, Gosnell J, Lewiecki EM, Singer FR, Gittoes N, Khan AA, Marcocci C, Rejnmark L, Ye Z, Guyatt G, Potts JT. Bilezikian JP, et al. Among authors: khan aa. J Bone Miner Res. 2022 Nov;37(11):2391-2403. doi: 10.1002/jbmr.4682. Epub 2022 Oct 17. J Bone Miner Res. 2022. PMID: 36054638 Free article.
Management of Hypoparathyroidism.
Khan AA, Guyatt G, Ali DS, Bilezikian JP, Collins MT, Dandurand K, Mannstadt M, Murphy D, M'Hiri I, Rubin MR, Sanders R, Shrayyef M, Siggelkow H, Tabacco G, Tay YD, Van Uum S, Vokes T, Winer KK, Yao L, Rejnmark L. Khan AA, et al. J Bone Miner Res. 2022 Dec;37(12):2663-2677. doi: 10.1002/jbmr.4716. Epub 2022 Oct 31. J Bone Miner Res. 2022. PMID: 36161671
Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia.
Jan de Beur SM, Minisola S, Xia WB, Abrahamsen B, Body JJ, Brandi ML, Clifton-Bligh R, Collins M, Florenzano P, Houillier P, Imanishi Y, Imel EA, Khan AA, Zillikens MC, Fukumoto S. Jan de Beur SM, et al. Among authors: khan aa. J Intern Med. 2023 Mar;293(3):309-328. doi: 10.1111/joim.13593. Epub 2022 Dec 13. J Intern Med. 2023. PMID: 36511653 Free PMC article. Review.
Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma.
Song X, Kelley RK, Khan AA, Standifer N, Zhou D, Lim K, Krishna R, Liu L, Wang K, McCoon P, Negro A, He P, Gibbs M, Kurland JF, Abou-Alfa GK. Song X, et al. Among authors: khan aa. Clin Cancer Res. 2023 Feb 16;29(4):754-763. doi: 10.1158/1078-0432.CCR-22-1983. Clin Cancer Res. 2023. PMID: 36477555 Free PMC article. Clinical Trial.
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial.
Khan AA, Rubin MR, Schwarz P, Vokes T, Shoback DM, Gagnon C, Palermo A, Marcocci C, Clarke BL, Abbott LG, Hofbauer LC, Kohlmeier L, Pihl S, An X, Eng WF, Smith AR, Ukena J, Sibley CT, Shu AD, Rejnmark L. Khan AA, et al. J Bone Miner Res. 2023 Jan;38(1):14-25. doi: 10.1002/jbmr.4726. Epub 2022 Nov 12. J Bone Miner Res. 2023. PMID: 36271471 Free PMC article. Clinical Trial.
2,707 results